My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

102.26 +7.29 (+7.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,336,131
Open 94.97
Bid (Size) 101.95 (3)
Ask (Size) 103.80 (1)
Prev. Close 94.97
Today's Range 94.97 - 102.35
52wk Range 68.70 - 156.66
Shares Outstanding 153,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI
San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic... 
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent... 
Via MarketMinute
Topics Artificial Intelligence Economy Government

Performance

YTD
-21.9%
-21.9%
1 Month
+4.5%
+4.5%
3 Month
+1.9%
+1.9%
6 Month
+24.9%
+24.9%
1 Year
-20.7%
-20.7%

More News

Read More
Why Is Illumina (ILMN) Stock Rocketing Higher Today
Via StockStory
Topics Artificial Intelligence Lawsuit Whistleblower
Illumina Stock Surged 6% Today – Here’s Why
Via Stocktwits
Topics Artificial Intelligence
Nvidia's AI Reign Ignites Stock Futures: A Trillion-Dollar Trajectory Reshapes the Market
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Illumina Inc (NASDAQ:ILMN) Presents a Compelling Value Investment Case
Via Chartmill
3 Healthcare Stocks That Fall Short
Via StockStory
Topics Stocks
AI Takes Center Stage in Biodefense: DARPA's NODES Program Promises to Revolutionize Pandemic and Biowarfare Protection
Via MarketMinute
Topics Artificial Intelligence
Trump Administration Review Targets Medical Supply Chain Vulnerabilities
Via Benzinga
Topics Economy Government Supply Chain
The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care
Via MarketMinute
Topics Artificial Intelligence
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years
Via Benzinga
Why Illumina (ILMN) Stock Is Falling Today
Via StockStory
Topics Economy Lawsuit Whistleblower
Astrana Health, Privia Health, Illumina, Waters Corporation, and LeMaitre Shares Plummet, What You Need To Know
Via StockStory
Topics Economy
Illumina (ILMN): Buy, Sell, or Hold Post Q2 Earnings?
Via StockStory
Topics Government Stocks
ILLUMINA INC (NASDAQ:ILMN) Screens as a Decent Value Stock for Investors
Via Chartmill
Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN)
Via StockStory
Topics Artificial Intelligence Economy
AdaptHealth, Illumina, Globalstar, Iridium, and Alight Shares Are Soaring, What You Need To Know
Via StockStory
Topics ETFs Economy
3 Cash-Producing Stocks We Keep Off Our Radar
Via StockStory
Icahn Hedge Fund's Q2 Moves: Centuri Stake Soars, JetBlue Held, 2 Positions Exited
Via Benzinga
NICE Stock Stops Being Nice, Has A Bearish Breakdown
Via Benzinga
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy
Illumina’s Q2 Earnings Call: Our Top 5 Analyst Questions
Via StockStory
Topics Earnings World Trade
ILMN Q2 Deep Dive: Clinical Demand Cushions Revenue Decline Amid Research Weakness and Margin Pressures
Via StockStory
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know
Via StockStory
Topics Bonds Economy Stocks
Latin America’s Next-Generation Sequencing (NGS) Market Set to Reach $597.2 Million by 2034, Driven by Cancer Genomics and Personalized Medicine
Via AB Newswire

Frequently Asked Questions

Is Illumina, Inc. - Common Stock publicly traded?
Yes, Illumina, Inc. - Common Stock is publicly traded.
What exchange does Illumina, Inc. - Common Stock trade on?
Illumina, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Illumina, Inc. - Common Stock?
The ticker symbol for Illumina, Inc. - Common Stock is ILMN on the Nasdaq Stock Market
What is the current price of Illumina, Inc. - Common Stock?
The current price of Illumina, Inc. - Common Stock is 102.26
When was Illumina, Inc. - Common Stock last traded?
The last trade of Illumina, Inc. - Common Stock was at 10/01/25 04:00 PM ET
What is the market capitalization of Illumina, Inc. - Common Stock?
The market capitalization of Illumina, Inc. - Common Stock is 15.72B
How many shares of Illumina, Inc. - Common Stock are outstanding?
Illumina, Inc. - Common Stock has 16B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.